Skip to content

Insider · CIK 0001863130

Paul Andrea

Reports to the SEC for 2 companies · SAN DIEGO, CA

Transactions

12

Companies

2

Filings

6

CIK

0001863130

Forms 4 and 5

Insider transactions

12 trades
DateCompanyValue
2025-02-03ZNTLZentalis Pharmaceuticals, Inc.A Award—
2025-02-03ZNTLZentalis Pharmaceuticals, Inc.S Sale−$22.6K
2025-02-03ZNTLZentalis Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award—
2024-02-02ZNTLZentalis Pharmaceuticals, Inc.S Sale−$38.2K
2024-02-01ZNTLZentalis Pharmaceuticals, Inc.A Award—
2024-02-01ZNTLZentalis Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award—
2024-02-01ZNTLZentalis Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award—
2023-02-01ZNTLZentalis Pharmaceuticals, Inc.A Award—
2023-02-01ZNTLZentalis Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award—
2022-08-01ZNTLZentalis Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award—
2022-03-01LogicBio Therapeutics, Inc.Stock Option (right to buy)A Award—
2021-05-17LogicBio Therapeutics, Inc.Employee Stock Option (Right to buy)A Award—

Recent filings

6

Companies

2

Address

C/O ZENTALIS PHARMACEUTICALS, INC. 10275 SCIENCE CENTER DRIVE, SUITE 200

SAN DIEGO, CA, 92121